Skincare Science · Acne + Oil Control
Salicylic Acid for Oily and Acne-Prone Skin: What It Does
Salicylic acid is a beta-hydroxy acid (BHA) that dissolves in oil, penetrates inside the pore, and loosens the debris that forms blackheads, whiteheads, and inflammatory breakouts. Multiple RCTs show it reduces total lesion counts by 40 to 62% over 8 to 12 weeks32 and lowers sebum output,11 with a tolerability profile that competes directly with benzoyl peroxide and adapalene.
Not all exfoliants work the same way. Glycolic acid (an AHA) works at the skin's surface. Salicylic acid works inside the follicle. That difference is why it tends to outperform AHAs specifically on comedone-type breakouts, and why it's been a first-line OTC option for acne since the 1970s. This guide covers the mechanism, the clinical data, how to actually use it without wrecking your barrier, and an honest look at where it fits alongside other oil-control actives.
// What's in this guide
01What is salicylic acid?
Salicylic acid (SA) is a naturally occurring compound originally derived from willow bark, now synthesized for cosmetic and pharmaceutical use. In skincare, it belongs to the beta-hydroxy acid (BHA) class, which means the hydroxyl group sits one carbon further from the carboxylic acid group compared to an alpha-hydroxy acid like glycolic acid. That structural difference gives SA one defining property: it is lipophilic (oil-soluble) rather than water-soluble.
That single fact explains almost everything about why it works for oily and acne-prone skin. AHAs dissolve in water and exfoliate at the surface. SA dissolves in sebum, allowing it to penetrate into the follicular opening, which is filled with oil, and work on the clogged material from inside. A 2015 comprehensive review in Clinical, Cosmetic and Investigational Dermatology describes SA's primary action as desmolytic rather than simply keratolytic: it disrupts the desmosomes, the cellular junctions between corneocytes, which is what actually loosens the compact plug of dead cells inside a comedone rather than just dissolving surface cells.10
Over-the-counter concentrations range from 0.5% to 2% in leave-on products (toners, serums, gels, moisturizers) and cleansers. Professional-grade peels go up to 20% to 30%, and medical-grade peels reach 50%. For most people reading this, 0.5% to 2% in a leave-on formula is the relevant range. That's where the bulk of clinical data sits, and it's what you'll find labeled as "acne treatment" on pharmacy shelves anywhere in the world. See our foundational skincare routine for where SA fits in a broader regimen.
Salicylic acid is oil-soluble, so it travels through sebum into the pore itself rather than staying at the skin surface. That's the core reason it outperforms water-soluble acids for comedonal acne specifically. Its primary mechanism is desmolysis: loosening the cellular glue that keeps pores blocked.
02How salicylic acid works inside pores: 3 mechanisms
1. Pore exfoliation (desmolysis)
The follicular plug that forms a whitehead or blackhead is essentially dead corneocytes held together by intercellular lipids and desmosomal proteins. SA disrupts those bonds rather than just dissolving the cells at the surface. A 1989 clinical study found that SA cleanser was the only treatment that produced significant comedone reduction in a crossover design versus benzoyl peroxide wash, and patients who switched from SA to benzoyl peroxide actually worsened, suggesting SA-specific activity on comedone structure.9 The 2015 review confirms that the desmolytic mechanism drives SA's particular strength on blackheads and closed comedones, not just inflamed papules.10
2. Sebum suppression via AMPK/SREBP-1
SA does more than remove existing plugs. A 2019 in vitro and rabbit-ear model study in Experimental Dermatology found that SA suppresses the AMPK/SREBP-1 pathway in sebocytes, directly reducing lipogenesis (the production of the sebum that forms the plugs in the first place), and also suppresses the NF-kB inflammatory pathway in those same cells.11 This dual mechanism, clearing what's already there while reducing what's produced, is part of why clinical results accumulate over weeks rather than appearing overnight. The sebum suppression data also explains why a 2011 single-blind RCT found that SA actually decreased sebum excretion while tretinoin did not, despite tretinoin having faster initial lesion impact.12
3. Anti-inflammatory action
SA inhibits the cyclooxygenase (COX) pathway, the same pathway targeted by aspirin (which is a derivative of salicylic acid). Applied topically, it suppresses the production of prostaglandins and other inflammatory mediators that drive the redness, swelling, and pain of inflamed papules and pustules. This is why a 2003 double-blind RCT found that a SA combination cream produced inflammatory lesion reductions of 62% and non-inflammatory of 56%, comparable to 5% benzoyl peroxide, but with significantly fewer adverse skin effects.13 The anti-inflammatory component also explains why SA tends to leave the skin calmer during use than retinoids do, which increase cell turnover but can drive initial irritation. This is also relevant for understanding how SA and niacinamide work together: read more in our niacinamide for oily skin guide.
Salicylic acid attacks acne from three angles at once: it physically loosens pore plugs (desmolysis), reduces sebum production at the source (AMPK/SREBP-1 suppression), and suppresses the inflammatory response that makes lesions red and painful. No single mechanism alone explains its full effect.
03The clinical evidence: what studies actually show
Salicylic acid has a larger and more consistent body of clinical data than most OTC acne actives. The honest summary: it works well for mild to moderate comedonal and inflammatory acne, it is well-tolerated, and its evidence competes directly with benzoyl peroxide. Where evidence is weaker or mixed, that's noted below.
| Study | Design | Duration | Key result | Evidence strength |
|---|---|---|---|---|
| Dreno et al. (2024) | RCT (n=150), SA-based cream vs 5% BPO | 12 weeks | 62.2% responders SA vs 50.0% BPO; superior tolerability | Strong |
| Multicenter RCT (2024) | RCT (n=500), 2% SSA hydrogel vs adapalene gel | 16 weeks | 51.01% SA vs 43.10% adapalene regression/marked improvement | Strong |
| Split-face RCT (2019) | RCT (n=31), 2% SSA vs 5% BPO + 0.1% adapalene | Variable | Papule/pustule: 47.9% SA vs 49.8% combo. Non-inflammatory: 43.1% vs 42.7%. No significant difference | Strong |
| Leyden et al. (2010) | Meta-analysis (23 studies, n=7,309) | 2-12 weeks | BPO+SA: 55.2% early inflammatory reduction at 2-4 weeks | Strong |
| Prospective trial (2025) | Observational (n=42), 2% SA + niacinamide + ceramides | 21 days | Sebum -23.65%, hydration +40.5%, TEWL -49.26%, IGA improved 23.81% | Moderate |
| Draelos et al. (2013) | Open-label OTC BPO+SA foam (two trials) | 8-12 weeks | -56.9% (8 wk) and -61.6% (12 wk) total lesion reduction | Moderate |
| Cochrane review (2020) | Systematic review (49 RCTs, n=3,880) | Various | SA vs tretinoin: RR 1.00 (no difference). Evidence quality: low-to-very-low for SA alone | Mixed |
| AAD Guidelines (2024) | GRADE practice guidelines | N/A | Conditional recommendation for SA; BPO and topical retinoids receive stronger recommendations | Mixed |
The 2024 multicenter RCT is particularly noteworthy: it enrolled 500 subjects, making it one of the larger SA-specific acne trials, and found 2% supramolecular salicylic acid hydrogel comparable to adapalene gel (a prescription-strength retinoid) at 16 weeks, with fewer adverse events.2
The honest caveat is the Cochrane review: it found low-to-very-low quality evidence for SA monotherapy when evaluated using strict GRADE criteria, primarily because many older trials had design weaknesses. That doesn't mean SA doesn't work. It means the older trials weren't designed to pharmaceutical-study standards. The more recent RCTs (2019, 2024) are better designed and consistently show meaningful lesion reductions.5
The AAD's 2024 guidelines give SA a conditional recommendation while reserving stronger grades for BPO and topical retinoids.7 For clinical context, a conditional recommendation means SA is appropriate when chosen for patient-specific reasons, such as BPO intolerance, preference for OTC, or a comedone-dominant presentation. It doesn't mean SA is a consolation prize. Understanding your own skin barrier is central here: see our guide to how to repair the skin barrier for the foundational context.
SA consistently reduces acne lesions by 40 to 62% over 8 to 12 weeks in RCTs. It performs comparably to benzoyl peroxide and adapalene in head-to-head trials, often with better tolerability. Its conditional guideline status reflects older study quality, not clinical ineffectiveness. For mild to moderate comedonal and inflammatory acne, it's a well-supported first-line OTC choice.
04How to use salicylic acid without barrier damage
The most common way people undermine SA's effectiveness is not under-dosing, it's over-exfoliating. Using it twice a day on a compromised barrier, layering with other acids, and skipping moisturizer collectively strip the barrier and produce redness, flaking, and tightness that looks like an allergic reaction but is usually just mechanical over-exfoliation. Here's what the clinical data supports:
Start slow, build frequency
A 2012 sandalwood oil + SA open-label trial (n=47) found that mild tolerance issues peaked at week 2 and resolved by week 8 with continued use.16 That pattern is typical. If you introduce SA two to three times per week for the first two weeks and then move to daily use, you give your barrier time to adapt. Starting daily from day one is where most of the "it burned my face" reviews come from.
Formulation type changes contact time
Cleansers leave SA on the skin for a few seconds to minutes. Toners and essences leave it for longer. Leave-on serums and gels leave it all day or night. A 2025 study on a novel SA cleanser with polymeric technology found it delivered acne reduction from week 4 while maintaining skin barrier integrity, specifically because the short contact time and polymer technology reduced barrier disruption compared to conventional SA cleansers.6 If you're new to SA or have a sensitive or compromised barrier, start with a cleanser rather than a leave-on product.
Pair with barrier-supporting ingredients
The 2025 prospective trial showing sebum reduction of 23.65% and barrier hydration improvement of 40.5% at 21 days used 2% SA in combination with niacinamide and ceramides, not SA alone.8 That combination approach, exfoliate and support, is consistently better-tolerated and likely more effective than SA in isolation. A ceramide-rich moisturizer after SA, or a formula that combines SA with barrier ingredients, protects the skin while the acid does its work. MAXXING's Clear Dominance serum (niacinamide 5% + zinc) is not a salicylic acid product, but it supports the oil-control layer of a routine through a different mechanism: niacinamide suppresses sebum excretion rate and zinc supports the barrier. The two can work in the same routine, used at different steps or times.
Where SA fits in a routine
- Cleanser with SA: use morning or evening as your first step, rinse off.
- Leave-on SA toner or serum: apply after cleansing, before moisturizer. Let it fully absorb (30 to 60 seconds) before the next step.
- Do not layer with another exfoliating acid in the same routine. If you use a retinoid, use SA in the morning and retinoid at night, or alternate nights.
- Morning users: always follow with SPF. SA does not increase photosensitivity the way retinoids do, but freshly exfoliated skin is more vulnerable to UV damage regardless.
05Side effects and what to watch for
SA is one of the better-tolerated OTC acne actives, but it's not entirely free of side effects. Most are mild, predictable, and avoidable:
Dryness and mild initial peeling
The most common reaction, particularly in the first one to two weeks at daily frequency. Multiple RCTs list this as the most frequently reported adverse event, and in essentially all cases it is mild and transient. Adding a non-comedogenic moisturizer (after SA has absorbed) resolves most dryness without blunting the exfoliating effect.
Initial skin purging
Some people see a brief increase in breakouts in the first two to three weeks as SA loosens and expels existing congestion from follicles. This is not the product failing. It follows a predictable timeline: the initial congestion was already there, SA just brings it to the surface faster. If purging lasts beyond four weeks or the new breakouts are in areas where you've never broken out before, that's more likely irritation or another product interaction than purging.
Barrier disruption from overuse
Using high concentrations daily on an already-compromised barrier, or layering SA with multiple other acids in the same routine, can meaningfully increase transepidermal water loss (TEWL). The 2025 novel-cleanser study specifically measured TEER (transepidermal electrical resistance, a barrier-integrity marker) to show its formulation avoided this problem.6 The lesson: formulation and frequency matter as much as concentration.
Salicylism (rare, relevant for professionals)
Systemic salicylate toxicity from topical SA is theoretical at OTC concentrations but has been documented with high-concentration peels over large body surface areas. A 2015 comprehensive review confirms rare systemic toxicity at standard cosmetic doses, but notes it's a real consideration for large-area applications and peels above 20%.10 At 0.5% to 2% on the face, this is not a practical concern for most people.
Mild initial dryness and a brief purge period are normal and usually self-limiting. Barrier disruption from overuse is avoidable with correct frequency and formulation. Combine SA with a non-comedogenic moisturizer and build frequency gradually. If your skin is significantly dehydrated or compromised, repair the barrier first before adding an exfoliating acid.
06Oil-control approaches compared
Salicylic acid is one of several well-evidenced topical approaches to oily and acne-prone skin. They work through different mechanisms, suit different skin states, and sit at different price points. The table below uses anonymized product specs drawn from publicly available formulas, with MAXXING's offering honestly positioned.
MAXXING does not sell a salicylic acid product. Clear Dominance is a niacinamide 5% + zinc serum that supports oil control through a different mechanism: niacinamide suppresses sebum excretion rate and supports barrier function, while zinc helps regulate sebum production and supports calm-looking skin. It is not a BHA and does not exfoliate pores. If your primary concern is comedone clearance, SA is the right mechanism. If your primary concern is ongoing sebum regulation and supporting the barrier while controlling shine, niacinamide and zinc are well-suited options. Many people benefit from both in the same routine at different steps.
| Approach / product type | Active(s) | Primary mechanism | Best for | Pore exfoliation | Sebum reduction | Barrier-friendly | Approx. price range |
|---|---|---|---|---|---|---|---|
| Budget water-based niacinamide serum | Niacinamide 10%, Zinc PCA 1% | Sebum regulation, barrier support | All skin types; shine control; daily maintenance | No | Yes | Yes | $6 / 30ml |
| Premium multi-active niacinamide serum | Niacinamide 10%, Zinc PCA 1%, Vitamin C, Licorice Root | Sebum regulation, tone-evening, barrier support | Acne-prone skin with post-breakout marks; multi-concern | No | Yes | Yes | $49 / 20ml |
| High-potency single-active niacinamide | Niacinamide 12-15%, Zinc PCA 1-2% | Sebum regulation, pore appearance, oil control | Oily skin with visible pores; post-acne marks; brightening | No | Yes | Yes | $17-25 / 30ml |
| MAXXING Clear Dominance Our pick | Niacinamide 5%, Zinc PCA | Sebum support, barrier function, calm skin appearance | Oily + acne-prone skin; combining with SA routine; barrier care | No | Yes | Yes | trymaxxing.com |
| OTC 2% salicylic acid leave-on gel / serum | Salicylic acid 2% | Pore exfoliation (desmolysis), anti-inflammatory | Comedonal acne; blackheads; active breakouts | Yes | Yes | Use with care | $10-30 / 30ml |
| OTC salicylic acid cleanser | Salicylic acid 0.5-2% | Pore exfoliation (short contact time) | Mild acne; barrier-sensitive users starting SA; combination skin | Yes (mild) | Moderate | Better than leave-on | $8-20 / bottle |
The comparison makes clear that SA and niacinamide-based oil control are not competing for the same role. SA clears what's already blocking the pore. Niacinamide + zinc reduces what's produced going forward, supports the barrier, and addresses post-breakout marks. A well-constructed routine for oily, acne-prone skin would use both: SA in the cleansing or treatment step, niacinamide in the serum layer. For more on the niacinamide side of this, see our niacinamide for oily skin guide.
07Salicylic acid across skin types
Oily skin
The most direct fit. SA's lipophilicity means it uses the skin's own excess sebum as a delivery vehicle, distributing into follicles where oil concentration is highest. For classic oily skin with blackheads, large pores, and mid-face shine, a 2% leave-on product (toner, serum, or gel) is the standard starting point. The sebum-suppression data supports this approach beyond just physical clearance: SA supports a reduction in ongoing sebum production, not just clearance of existing plugs.11
Combination skin
The common T-zone congestion pattern responds well to SA applied specifically to oily zones. The 2015 comprehensive review notes that SA distributes selectively into sebaceous follicles rather than uniformly across the skin surface, which makes it a reasonable candidate for spot-treating or zonal application without over-drying the drier parts of the face.10
Dry or sensitive skin
Possible, but requires more careful approach. Start with a cleanser format rather than a leave-on, and prioritize barrier repair before adding SA. A 2025 observational trial using 2% SA alongside ceramides and niacinamide found barrier hydration actually improved by 40.5% at 21 days, which suggests that pairing SA with barrier-supporting ingredients changes the outcome substantially.8 If your skin barrier is already compromised, fix the barrier first. Our barrier repair guide is the right starting point.
Darker skin tones (Fitzpatrick IV-VI)
A concern sometimes raised is whether SA increases post-inflammatory hyperpigmentation (PIH) risk in darker skin. The evidence says no, particularly at OTC concentrations. The 1999 Dermatology Surgery study specifically evaluated 20% to 30% SA peels in Fitzpatrick V-VI skin and found 88% moderate-to-significant improvement with only 16% mild adverse reactions and no cases of SA-induced PIH.14 A 2015 split-face RCT in Fitzpatrick III-V found 30% SA peels achieved 95% total improvement versus TCA 25% at 85%.15 At OTC 2% concentrations, the tolerability profile in darker skin is strong. The usual advice stands: build slowly, keep the barrier healthy, and use SPF daily.
Adolescent and adult acne
SA has a broad age range of appropriate use. A 2012 open-label study in adolescents and adults with mild to moderate acne found 89.4% met their primary endpoint over 8 weeks using a 0.5% SA + sandalwood oil regimen, with tolerance issues peaking at week 2 and resolving by week 8.16 For adult hormonal acne, SA is typically more effective for the comedonal component than for deep cystic lesions, which often need prescription intervention.
08FAQ
Salicylic acid is a beta-hydroxy acid (BHA) that works inside the pore rather than at the surface. It is lipophilic, meaning it dissolves in oil and can penetrate sebum-filled follicles. Once inside, it loosens the cellular glue that causes dead skin cells to clump together and block pores (a process called desmolysis), promotes exfoliation of the follicular lining, and suppresses inflammatory pathways that drive papules and pustules. The result, supported by multiple RCTs, is a reduction in both non-inflammatory lesions (blackheads, whiteheads) and inflammatory lesions (red papules, pustules).
For over-the-counter leave-on products, 0.5% to 2% is the standard and well-supported range. Clinical studies consistently use 2% in leave-on formulas (serums, gels, toners) and show meaningful reductions in both inflammatory and comedonal lesions. Below 0.5%, evidence is thinner. Professional peels use 20% to 30%. There is no clear evidence that going higher than 2% in a daily leave-on formula delivers better outcomes for most people, and it increases the chance of dryness and barrier disruption.
Most clinical trials show measurable lesion reduction starting at week 2 to 4 of consistent daily use. Significant reductions, typically 40% to 62% in total lesion counts, appear by week 8 to 12. One 2025 prospective trial found sebum reduced by 23.65% and barrier hydration improved by 40.5% at just 21 days. The speed depends on lesion type: whiteheads and blackheads respond faster than deep cystic acne, which may need a prescription-strength approach alongside any OTC routine.
At standard OTC concentrations (0.5% to 2%) in well-formulated products, barrier disruption is minimal and usually reversible. The concern is real with high-concentration peels or daily over-exfoliation: multiple applications per day, layering with other acids, and very dry or compromised skin can collectively stress the barrier. A 2025 study found that a novel 2% SA cleanser using polymeric technology actually maintained skin barrier integrity (measured by TEER) while delivering the acne benefit, suggesting formulation matters as much as concentration.
For most people with oily or acne-prone skin, daily use of a 0.5% to 2% leave-on product is well-tolerated once the skin has been introduced to it gradually. Starting at two to three times per week and building to daily over two to four weeks gives your barrier time to adapt and reduces the chance of initial dryness. Cleansers with SA are even gentler as a starting point because the contact time is shorter. If dryness, flaking, or tightness appears, pull back frequency before reducing concentration.
Yes. A 1999 Dermatology Surgery study specifically evaluated 20% to 30% SA peels in people with Fitzpatrick skin types V and VI, reporting moderate-to-significant improvement in 88% of participants and only 16% mild adverse reactions, with no instances of post-inflammatory hyperpigmentation at those concentrations. At OTC leave-on levels (0.5% to 2%), SA has a strong tolerability record across all Fitzpatrick types. The key risk with any actives in darker skin is PIH from barrier disruption, so the same advice applies: build slowly, keep the barrier healthy, and avoid over-exfoliating.
Yes, this is one of the better-supported combinations for oily and acne-prone skin. A 2025 open-label split-face trial used a serum combining 0.2% SA, 2% niacinamide, lactic acid, and HEPES and found significant reductions in inflammatory lesions and improved pore appearance at 8 weeks. Niacinamide supports barrier function and reduces sebum production via a different mechanism than SA, so the two complement rather than overlap. A separate 2025 prospective trial found that 2% SA plus niacinamide plus ceramide gel reduced sebum by 23.65% and improved barrier hydration by 40.5% at 21 days.
Salicylic acid supports the look of post-inflammatory hyperpigmentation (PIH) primarily through its exfoliating action, which accelerates turnover of pigmented surface cells. A 2009 RCT found that SA-mandelic acid peels outperformed glycolic acid for both active acne and hyperpigmentation. At OTC concentrations, the effect on established PIH is modest but real over 8 to 12 weeks. Combining SA with niacinamide (which supports melanin transfer reduction) and consistent sun protection is the most practical at-home approach for post-acne marks.
The most common downsides are dryness, mild peeling, and temporary tightness, especially during the first two to four weeks of use. Over-exfoliation from stacking multiple acids can weaken the skin barrier. SA is not suitable during pregnancy at high concentrations (consult a professional). People with aspirin sensitivity should check with a doctor before use. At standard OTC levels (0.5% to 2%), serious side effects are rare when you introduce it gradually.
// References
- Atanaskova Mesinkovska N, Bergfeld WF. Hair: what is new in diagnosis and management? Dermatol Clin. 2013. [Context: overview of SA mechanism.] pubmed.ncbi.nlm.nih.gov/30173582
- Multicenter randomized controlled trial (n=500). 2% supramolecular salicylic acid hydrogel vs adapalene gel in mild to moderate acne vulgaris. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16238. pubmed.ncbi.nlm.nih.gov/38590107
- Dreno B et al. Efficacy of a multitargeted, salicylic acid-based dermocosmetic cream compared to benzoyl peroxide 5% in acne vulgaris. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16052. pubmed.ncbi.nlm.nih.gov/37941097
- Leyden J et al. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. Journal of the American Academy of Dermatology. 2010. doi:10.1016/j.jaad.2009.07.052. pubmed.ncbi.nlm.nih.gov/20488582
- Ebede TL et al. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Cochrane Database of Systematic Reviews. 2020. doi:10.1002/14651858.CD011368.pub2. pubmed.ncbi.nlm.nih.gov/32356369
- Novel 2% salicylic acid cleanser with polymeric cleansing technology treats acne without compromising skin barrier. Journal of Drugs in Dermatology. 2025. doi:10.36849/JDD.9019. pubmed.ncbi.nlm.nih.gov/40465501
- Zaenglein AL et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2024. doi:10.1016/j.jaad.2023.12.017. pubmed.ncbi.nlm.nih.gov/38300170
- Clinical efficacy of a salicylic acid-containing gel on acne management and skin barrier function: a 21-day prospective study. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70353. pubmed.ncbi.nlm.nih.gov/40682377
- Shalita A et al. Comparison of a salicylic acid cleanser and a benzoyl peroxide wash in the treatment of acne vulgaris. Clinical Therapeutics. 1989. pubmed.ncbi.nlm.nih.gov/2525420
- Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clinical, Cosmetic and Investigational Dermatology. 2015. doi:10.2147/CCID.S84765. pmc.ncbi.nlm.nih.gov/articles/PMC4554394
- Zhao YE et al. Salicylic acid treats acne vulgaris by suppressing AMPK/SREBP1 pathway in sebocytes. Experimental Dermatology. 2019. doi:10.1111/exd.13934. pubmed.ncbi.nlm.nih.gov/30972839
- Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in acne vulgaris. Journal of the European Academy of Dermatology and Venereology. 2011. doi:10.1111/j.1468-3083.2010.03793.x. pubmed.ncbi.nlm.nih.gov/20666879
- Gupta AK et al. Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in acne vulgaris. Drugs Exp Clin Res. 2003. pubmed.ncbi.nlm.nih.gov/14708455
- Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatology Surgery. 1999. doi:10.1046/j.1524-4725.1999.08145.x. pubmed.ncbi.nlm.nih.gov/9935087
- El-Domyati M et al. Trichloroacetic acid versus salicylic acid in the treatment of acne vulgaris in dark-skinned patients. Dermatology Surgery. 2015. doi:10.1097/DSS.0000000000000522. pubmed.ncbi.nlm.nih.gov/26551771
- Kircik LH. Single-center, open-label study of a 0.5% salicylic acid-based treatment regimen in adolescents and adults with mild to moderate acne. Journal of Drugs in Dermatology. 2012. pubmed.ncbi.nlm.nih.gov/23377508
- Evaluation of a dermocosmetic serum containing SA + niacinamide in Japanese women with mild acne. The Journal of Clinical and Aesthetic Dermatology. 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12007656
